Shares of Revance Therapeutics surged 18% Thursday after the company announced the Food and Drug Administration had approved Daxxify.
The company says Daxxify can diminish wrinkles for up to six months, twice as long as Botox.
The FDA’s decision comes years after Revance submitted Daxxify for approval, encountering delays due to the Covid-19 pandemic as well asMore than $14.6 billion. That’s how much the U.S. aesthetics procedures market was worth in 2021,Botox, which is derived from a toxin produced by the bacteria clostridium botulinum, was initially used to create a drug to treat two rare eye muscle disorders.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves New Botox RivalThe U.S. Food and Drug Administration approved a new antiwrinkle treatment that could be the most formidable challenger to date to market leader Botox
Read more »
More U.S. adults receiving mental health treatment since start of pandemicMore U.S. adults are receiving mental health treatment. Nearly 22% of all adults received some form of treatment in 2021 — up from about 19% just two years earlier. Go deeper:
Read more »
Chicago influencer shares tale of bad botox treatment; 'I look like Two-Face''I started thinking about it, and realized that people didn't know this was a side effect. I didn't know it was a side effect, and decided that I should share what happened to me,' Whitney Buha said.
Read more »
Analysis | In praise of iron fists: Trump leans into his authoritarian instinctsThe pattern has long been that Trump tests the waters — and then jumps in.
Read more »
Gavin Newsom encounters an unexpected antagonist: Joe BidenCalifornia Gov. Gavin Newsom finds himself at odds with Biden and other Democrats over pro-union legislation in his home state.
Read more »
Rents continue to skyrocket in NYC, Here is the average rent nowRents jumped up around 23% last year in New York City.
Read more »